Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises KKR in connection with an additional investment in Söderberg & Partners
Mandate

Vinge advises KKR in connection with an additional investment in Söderberg & Partners

June 27, 2023 M&A

Söderberg & Partners has raised new capital for its continued international expansion. The current minority owner, KKR, has invested an additional amount of SEK 2.3 billion through a new issue of shares. Following the new issue of shares, KKR will remain as a significant minority shareholder in Söderberg & Partners together with TA Associates. However, control of the company remains with its founders and chairman of the board of directors.

Vinge’s team consisted of Christina Kokko, Samra Tesser and Maximilian Bengtsson.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026